DRUG TODAY 润色咨询

DRUGS OF TODAY

出版年份:1998 年文章数:620 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:3.2% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=71582052, cover=https://img.medsci.cn/images/journal/cover/2021/AHQ_202109271314529740.jpg, fullname=DRUGS OF TODAY, abbr=DRUG TODAY, pyear=1998, frequence=Monthly, articleNumbers=620, citedSelf2015=3.2, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=暂无数据, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=1699-3993, greenSci=https://www.greensci.net/search?kw=1699-3993, scijournal=https://www.scijournal.org/impact-factor-of-DRUG-TODAY.shtml, medsciHotlightString=null, medsciHotlightRealtime=1.653, medsciHotlight=1.72, medsciHotlight5year=2.3551, citescore=0.0, hIndex=52, impactFactor=1.8, orgnization=Prous Science, orgnizationUrl=http://lifesciences.thomsonreuters.com/prous, country=Spain, countryCn=西班牙, isOa=0, isOaString=否, sciScie=Science Citation Index Expanded|Current Contents - Clinical Medicine|BIOSIS Previews, bigclassCas=医学 4区, smallclassCas=医学 4 区, website=http://journals.prous.com/journals/servlet/xmlxsl/pk_journals.xml_journal_home_pr?p_JournalId=4, websiteHits=3647, guideForAuthor=null, guideForAuthorHits=1, submitWebsite=https://mc.manuscriptcentral.com/prous-thomsonreuters, submitWebsiteHits=1556, content=<span style="font-family: Verdana, Arial, Helvetica; color: rgb(0, 128, 0);"><p><b>AIMS & ORGANIZATION</b></p></span><span style="color: rgb(66, 62, 62); font-family: Verdana, Arial, Helvetica;"></span><p style="color: rgb(66, 62, 62); font-family: Verdana, Arial, Helvetica;"><i>Drugs of Today</i> is a peer-reviewed journal with a solid reputation of over 40 years in the scientific publications market. It is a valuable source of information on drugs introduced into the international market. Its updated monographs and articles keep the medical community abreast of the latest developments in diagnosis and treatment across therapeutic areas. This journal includes the following sections:</p><p style="color: rgb(66, 62, 62); font-family: Verdana, Arial, Helvetica;"><i>Monographs</i>, up-to-date reviews on recently approved and launched drugs prepared by leading specialists after a rigorous review of the literature and from information provided by pharmaceutical companies. Updates with new relevant information or on line extensions of marketed drugs (e.g., novel formulations, new indications, etc.) are also published.</p><p style="color: rgb(66, 62, 62); font-family: Verdana, Arial, Helvetica;"><i>Review articles</i>, highlighting the latest developments in the diagnosis and treatment of human diseases, as well as biomarkers for diagnosing diseases, monitoring treatment response, predicting toxicity and identifying candidates for targeted therapy.</p><p style="color: rgb(66, 62, 62); font-family: Verdana, Arial, Helvetica;"><i>Meeting reports</i>, conference reports providing highlights from key congresses and symposia around the world.</p><br style="color: rgb(66, 62, 62); font-family: Verdana, Arial, Helvetica;"><span style="font-family: Verdana, Arial, Helvetica; color: rgb(0, 128, 0);"><p><b>SELECTION OF TOPICS TO BE REVIEWED</b></p></span><span style="color: rgb(66, 62, 62); font-family: Verdana, Arial, Helvetica;"></span><p style="color: rgb(66, 62, 62); font-family: Verdana, Arial, Helvetica;">The Editorial Board comprises major authorities in their field who are selected to ensure that a wide variety of therapeutic areas are covered. The Board members recommend reviews from authorities within their field to guarantee that all topics are covered comprehensively and that all issues of current importance are emphasized. Submitted articles are peer reviewed before publication.</p><p style="color: rgb(66, 62, 62); font-family: Verdana, Arial, Helvetica;">Supplementary issues devoted to recently marketed drugs and symposia proceedings are periodically published. Supplements are written by leading specialists on the basis of current scientific literature and their own experience.</p><ul style="color: rgb(66, 62, 62); font-family: Verdana, Arial, Helvetica;"><li><p style="line-height: 1.3;">p-ISSN: 1699-3993, e-ISSN: 1699-4019 (B-47252-2009)</p></li><li><p style="line-height: 1.3;">Established: 1965</p></li><li><p style="line-height: 1.3;">Published: 12 issues/year and supplements</p></li><li><p style="line-height: 1.3;">Reader profile: Medical specialists, clinicians, marketing & corporate strategy directors, pharmacists & pharmacologists</p></li><li><p style="line-height: 1.3;">Indexed in: MEDLINE®/PubMed®, ISI® SciSearch®, BIOSIS Previews®, Current Contents® – Clinical Medicine, EMBASE, Science Citation Index Expanded™, Biological Abstracts®, Web of Science®, Journal Citation Reports® and Chemical Abstracts®</p></li></ul>, totalCites=1117, brief=DRUG TODAY杂志医学行业,“<strong><a target="_blank" href="/sci/index.do?smallclass=药学" >药学</a></strong>”子行业的偏低级别杂志, articleType=论著为主,其它类型文章约占5-10%, medsciHeat=<span style="color: #000000;">黑</span>, medsciComment=杂志水平一般,也很冷门,关注人少,审稿周期可能也不一定快,如果文章质量不佳,或时间不紧的话,可以考虑考虑。, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=71582052'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=null, citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=1.14), GetImpactFactorCiteScoreListResponse(year=2017, citescore=1.12), GetImpactFactorCiteScoreListResponse(year=2018, citescore=1.08), GetImpactFactorCiteScoreListResponse(year=2019, citescore=2.0), GetImpactFactorCiteScoreListResponse(year=2020, citescore=0.0)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=2.992), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=1.844), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=1.509), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=1.447), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=1.653)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Pharmacology (medical) , rank=144/232), GetImpactFactorCiteScoreGradeResponse(smallClass=Pharmacology, Toxicology and Pharmaceutics - Pharmacology , rank=203/300)], totalJcrAreaList=[GetImpactFactorCiteScoreGradeResponse(smallClass=PHARMACOLOGY & PHARMACY, rank=Q4)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1699-3993[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=DRUGS OF TODAY[ta], article_number=47, article_number_cn=7, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
DRUG TODAY/DRUGS OF TODAY
ISSN
1699-3993
影响指数话题
预警等级
MedSci期刊指数
1.653 (MedSci实时期刊指数) | 2.3551 (5年期刊指数)
CiteScore值
0.0
h-index
52
h5-median
暂无数据
出版社/管理机构
杂志由 Prous Science 出版或管理
出版国家/地区
Spain 西班牙
出版周期
Monthly
出版年份
1998
是否OA
被收录情况
Science Citation Index Expanded|Current Contents - Clinical Medicine|BIOSIS Previews
JCR分区
PHARMACOLOGY & PHARMACY Q4
中科院分区
大类:医学 4区
小类:医学 4 区